Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tacrolimus effect on rosacea.

Joel T M Bamford1, Barbara A Elliott, Irina V Haller

  • 1Dermatology Section, St. Mary's/Duluth Clinic Health System, MN 55805, USA. jbamford@smdc.org

Journal of the American Academy of Dermatology
|December 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Do they care?': a qualitative examination of patient perspectives on primary care clinician communication related to opioids in the USA.

BMJ open·2025
Same author

Pharmacist-led Transitions of Care: A Cohort Study on Admission Medication History Factors and Adjustments to the Discharge Medication List.

Hospital pharmacy·2024
Same author

The potential impact of clinical decision support on nonwaivered primary care clinicians' prescribing of buprenorphine.

Health affairs scholar·2024
Same author

A large, multi-center survey assessing health, social support, literacy, and self-management resources in patients with heart failure.

BMC public health·2024
Same author

The impact of multimorbidity and functional limitation on quality of life in patients with heart failure: A multi-site study.

Journal of the American Geriatrics Society·2024
Same author

Association of initial opioid prescription duration and an opioid refill by pain diagnosis: Evidence from outpatient settings in ten US health systems.

Preventive medicine·2023

Topical tacrolimus ointment effectively reduced erythema in patients with rosacea subtypes. However, it did not decrease papulopustular lesions, with side effects aligning with standard labeling.

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Rosacea is a chronic inflammatory skin condition.
  • Erythrotelangiectatic rosacea (ETR) and papulopustular rosacea (PPR) are common subtypes.
  • Current treatments aim to manage symptoms like erythema and inflammatory lesions.

Purpose of the Study:

  • To evaluate the efficacy and safety of 0.1% tacrolimus topical ointment.
  • To assess its impact on erythema and papulopustular lesions in rosacea patients.

Main Methods:

  • An open-label trial involving 24 patients with ETR or PPR.
  • Treatment with 0.1% tacrolimus topical ointment for 12 weeks.
  • Assessment of erythema and lesion counts.

Main Results:

Related Experiment Videos

  • Significant improvement in erythema for both ETR and PPR subtypes (P<.05).
  • No significant reduction in the number of papulopustular lesions observed.
  • Reported side effects were consistent with tacrolimus ointment labeling.

    • Conclusions:

    • 0.1% tacrolimus topical ointment demonstrates efficacy in reducing erythema associated with rosacea.
    • Tacrolimus may not be effective for the papulopustular component of rosacea.
    • Further research is warranted to explore its role in rosacea management.